국가: 아일랜드
언어: 영어
출처: HPRA (Health Products Regulatory Authority)
Clindamycin
Vetoquinol UK Limited
QJ01FF01
Clindamycin
25 mg/tablet
Tablet
POM: Prescription Only Medicine as defined in relevant national legislation
Cats, Dogs
clindamycin
Antibacterial
Authorised
2000-09-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Clindacyl 25 mg Tablets for dogs and cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCE Clindamycin 25 mg (as Clindamycin Hydrochloride) For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM A small white tablet, with a break line on one side and the letter J embossed on both sides of the break line. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and Cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Clindacyl 25 mg Tablets are antibiotics indicated for the treatment of infected wounds, abscesses, pyoderma and oral cavity/dental infections caused by or associated with clindamycin-sensitive staphylococci, streptococci, pneumococci, bacteroidaceae,_ Fusobacterium necrophorum, Clostridium perfringens_ and osteomyelitis caused by_ Staphylococcus_ _aureus_. Clindacyl 25 mg Tablets can also be used to help provide antimicrobial cover during dental procedures. 4.3 CONTRAINDICATIONS Do not administer to animals with hypersensitivity to clindamycin and lincomycin preparations. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. I R I S H M E D I C I N E S B O A R D ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _0_ _/_ _0_ _5_ _/_ _2_ _0_ _1_ _1_ _C_ _R_ _N_ _ _ _7_ _0_ _0_ _7_ _9_ _1_ _0_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS During prolonged osteomyelitis therapy of one month or greater, periodic liver and kidney function te 전체 문서 읽기